Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Circadian rhythms and tumor growth.

Greene MW.

Cancer Lett. 2012 May 28;318(2):115-23. doi: 10.1016/j.canlet.2012.01.001. Epub 2012 Jan 15. Review.

PMID:
22252116
2.
3.

Dim light melatonin onset (DLMO): a tool for the analysis of circadian phase in human sleep and chronobiological disorders.

Pandi-Perumal SR, Smits M, Spence W, Srinivasan V, Cardinali DP, Lowe AD, Kayumov L.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):1-11. Epub 2006 Aug 1. Review.

PMID:
16884842
4.

Light at night, chronodisruption, melatonin suppression, and cancer risk: a review.

Reiter RJ, Tan DX, Korkmaz A, Erren TC, Piekarski C, Tamura H, Manchester LC.

Crit Rev Oncog. 2007 Dec;13(4):303-28. Review.

PMID:
18540832
5.

Melatonin, sleep disturbance and cancer risk.

Blask DE.

Sleep Med Rev. 2009 Aug;13(4):257-64. doi: 10.1016/j.smrv.2008.07.007. Epub 2008 Dec 17. Review.

PMID:
19095474
6.

Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.

Srinivasan V, Spence DW, Pandi-Perumal SR, Trakht I, Cardinali DP.

Travel Med Infect Dis. 2008 Jan-Mar;6(1-2):17-28. doi: 10.1016/j.tmaid.2007.12.002. Epub 2008 Jan 28. Review.

PMID:
18342269
7.

Circadian disruption, shift work and the risk of cancer: a summary of the evidence and studies in Seattle.

Davis S, Mirick DK.

Cancer Causes Control. 2006 May;17(4):539-45. Review.

PMID:
16596308
8.

[Rhythms, depressions and light].

Johnsson A, Moan J.

Tidsskr Nor Laegeforen. 2006 Apr 6;126(8):1044-7. Review. Norwegian.

9.

Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics.

Lévi F, Filipski E, Iurisci I, Li XM, Innominato P.

Cold Spring Harb Symp Quant Biol. 2007;72:465-75. doi: 10.1101/sqb.2007.72.030. Review.

PMID:
18419306
10.

Phase shifting the human circadian clock using melatonin.

Lewy AJ, Ahmed S, Sack RL.

Behav Brain Res. 1996;73(1-2):131-4. Review.

PMID:
8788490
11.

The anti-tumor activity of pineal melatonin and cancer enhancing life styles in industrialized societies.

Bartsch C, Bartsch H.

Cancer Causes Control. 2006 May;17(4):559-71. Review.

PMID:
16596311
12.

Light and biological rhythms.

Wetterberg L.

J Intern Med. 1994 Jan;235(1):5-19. Review.

PMID:
8283159
13.

Light, melatonin and the sleep-wake cycle.

Brown GM.

J Psychiatry Neurosci. 1994 Nov;19(5):345-53. Review.

14.

[Melatonin in humans: a biochemical marker of the circadian clock and an endogenous synchronizer].

Claustrat B, Geoffriau M, Brun J, Chazot G.

Neurophysiol Clin. 1995;25(6):351-9. Review. French.

PMID:
8904197
15.

The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders.

Pandi-Perumal SR, Trakht I, Spence DW, Srinivasan V, Dagan Y, Cardinali DP.

Nat Clin Pract Neurol. 2008 Aug;4(8):436-47. doi: 10.1038/ncpneuro0847. Epub 2008 Jul 15. Review.

PMID:
18628753
16.

Tumor-based rhythms of anticancer efficacy in experimental models.

Granda TG, Lévi F.

Chronobiol Int. 2002 Jan;19(1):21-41. Review.

PMID:
11962677
17.

Artificial lighting in the industrialized world: circadian disruption and breast cancer.

Stevens RG.

Cancer Causes Control. 2006 May;17(4):501-7. Review.

PMID:
16596303
18.

[Melatonin: what for?].

Touitou Y.

Bull Acad Natl Med. 2005 May;189(5):879-89; discussion 889-91. Review. French.

PMID:
16433460
19.

Circadian disruption and breast cancer: from melatonin to clock genes.

Stevens RG.

Epidemiology. 2005 Mar;16(2):254-8. Review.

PMID:
15703542
20.

Photic and circadian regulations of melatonin rhythms in fishes.

Iigo M, Hara M, Ohtani-Kaneko R, Hirata K, Tabata M, Aida K.

Biol Signals. 1997 Jul-Dec;6(4-6):225-32. Review.

PMID:
9500660

Supplemental Content

Support Center